Radiopharm Theranostics (ASX:RAD) Buyback Yield % : -15.05 (As of Jun. 15, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Radiopharm Theranostics's current buyback yield was -15.05%.

Radiopharm Theranostics Buyback Yield % Historical Data

The historical data trend for Radiopharm Theranostics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Buyback Yield % Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Buyback Yield %

-155.29

-23.33

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Buyback Yield %	-88.13	-89.15	-69.40	0.10	-16.12

Competitive Comparison of Radiopharm Theranostics's Buyback Yield %

For the Biotechnology subindustry, Radiopharm Theranostics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Buyback Yield % falls into.

Radiopharm Theranostics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Radiopharm Theranostics's Buyback Yield for the fiscal year that ended in Jun. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-0.855	+	10.073)	/	39.51915
	=	-23.33%

Radiopharm Theranostics's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (-0.017	+	2.114)	*	2	/	26.01473
	=	-16.12%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Dec. 2023) data.

Radiopharm Theranostics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines